Axq Capital, LP Abb Vie Inc. Transaction History

Axq Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $591,334 - $673,770	3,700 New	3,700 $674 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $384,279 - $478,210	2,900 New	2,900 $391 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $951,711 - $1.14 Million	6,881 New	6,881 $1.11 Billion

3,795

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $308B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Axq Capital, LP with notifications on news.